Concepedia

Author

Thierry Gorlia

European Organisation for Research and Treatment of Cancer

Also Known As

Bromberg, Jacoline E. C., Gorlia, Thierry, T Gorlia, T. Gorlia, Thierry Gorlia

378

Publications

55.7K

Citations

64

H-Index

89

Concepts

All Affiliations

European Organisation for Research and Treatment of CancerErasmus MC Cancer InstituteUniversity Hospital of ZurichSorbonne UniversitéHeidelberg University
TG

About

Thierry Gorlia is an author at European Organisation for Research and Treatment of Cancer specializing in medicine, oncology, and glioma.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

34

58

14.6K

2

Health Sciences

21

32

2.7K

3

Biostatistics

3

3

742

4

Cell Biology

3

3

486

5

Engineering

1

1

420

Thierry Gorlia

×

130

Publications

54.4K

Citations

62

H-Index

YearCitations

Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

Roger Stupp, Warren Mason, Martin J. van den Bent,

New England Journal of Medicine

2005

21K

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Roger Stupp, Monika E. Hegi, Warren Mason,

The Lancet Oncology

2009

7.7K

<i>MGMT</i> Gene Silencing and Benefit from Temozolomide in Glioblastoma

Monika E. Hegi, Annie‐Claire Diserens, Thierry Gorlia,

New England Journal of Medicine

2005

7.1K

Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer

Jan B. Vermorken, Éva Remenár, Carla van Herpen,

New England Journal of Medicine

2007

1.7K

Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951

Martin J. van den Bent, Alba A. Brandes, Martin Taphoorn,

Journal of Clinical Oncology

2012

1.2K

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

Roger Stupp, Monika E. Hegi, Thierry Gorlia,

The Lancet Oncology

2014

1K

Lomustine and Bevacizumab in Progressive Glioblastoma

Wolfgang Wick, Thierry Gorlia, Martin Bendszus,

New England Journal of Medicine

2017

949

Adjuvant Procarbazine, Lomustine, and Vincristine Improves Progression-Free Survival but Not Overall Survival in Newly Diagnosed Anaplastic Oligodendrogliomas and Oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial

Martin J. van den Bent, Alba A. Brandes, Marc Sanson,

Journal of Clinical Oncology

2006

743

Stem Cell–Related “Self-Renewal” Signature and High Epidermal Growth Factor Receptor Expression Associated With Resistance to Concomitant Chemoradiotherapy in Glioblastoma

Anastasia Murat, Eugenia Migliavacca, Thierry Gorlia,

Journal of Clinical Oncology

2008

728

Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034

Martin J. van den Bent, Alba A. Brandes, R. Rampling,

Journal of Clinical Oncology

2009

561

Page 1